
AstraZeneca's vaccine has suffered reputational damage over the blood clotting furore. EPA
AstraZeneca's vaccine has suffered reputational damage over the blood clotting furore. EPA
AstraZeneca second jab does not increase risk of blood clots
Incidence of clotting in those twice vaccinated with AstraZeneca is comparable to typical rate